BD will be promoting its DecisIV range which includes BD Nexiva closed IV catheter system, BD Q-Syte luer access split septum and BD PosiFlush.
The BD Nexiva all-in-one closed IV catheter system is designed to reduce insertion attempts for first-stick success, as well as reduce exposure to blood though its blood-containment system. The system has been shown to reduce blood exposure by 98% during insertion, helping to reduce the potential for contamination and infection. Simple in design and function, devices such the BD Q-Syte luer access split septum system, eliminate the complexities of mechanical valves and, as a consequence, minimise the places that may harbour bacteria. BD PosiFlush is a range of ready-to-use sterile pre-filled flush syringes containing sodium chloride (NaCL) 0.9%, specifically designed to enhance best clinical practice. Studies have found that approximately 8% of manually prepared flush syringes are contaminated prior to administration due to breaks in aseptic technique. The use of commercially prepared BD PosiFlush can minimise this risk.
